In time of need: On hydroxychloroquine export.
Regardless of whether India bowed to U.S. pressure, it is unlikely to run out of the drug.
After enforcing a blanket restriction on the export of anti-malaria drug hydroxychloroquine on April 4, without exemptions on humanitarian or other premises, India reversed the policy 2 days later on The choice to reverse the restriction was revealed hours after U.S. President Donald Trump alerted of “retaliation” if India withheld supplies of the drug for which orders had currently been placed. Offered the scenarios, it would be tough to think that the choice to lift the restriction was taken independent of U.S. pressure. The pandemic has actually seen a number of countries displaying uniformity and cooperation providing vital supplies to others even while taking on the unique coronavirus in their own backyards. Prime Minister Narendra Modi’s message to Mr. Trump that “India shall do whatever possible to help mankind’s fight versus COVID-19” should, therefore, be seen because light. Admired as the pharmacy of the worldwide south, I